Weekly View

ICER Weekly View 09-14-18

From the desk of Mitchell Stein Good morning. Our thoughts are with those experiencing the ravages of Florence (and Typhoon Mangkhut in the Philippines). Earlier in the week to help prepare for the storm, HHS declared a public health emergency in North Carolina, South Carolina, and Virginia. While the event is not expected to have […]

Read More

ICER Weekly View 09-07-18

From the desk of Mitchell Stein Good morning. Did you miss me? These days, two weeks in the news cycle feels like an eternity. While I’ve focused on the more recent items, today’s issue includes items from the two weeks since we last met. As always, lots going on in the drug world. We’ll talk […]

Read More

ICER Weekly View 08-24-18

From the desk of Mitchell Stein Good morning. Before we get started, a scheduling note – with the approaching Labor Day holiday, there won’t be an edition next week, August 31. We’ll all meet back here in two weeks Friday, September 7 – until then remember, it’s chaos, be kind. Now, on to the news […]

Read More

ICER Weekly View 08-17-18

From the desk of Mitchell Stein   Good morning. This week we launched a probe to the sun. No, not connected to this week’s newsletter, but how cool is that? Or how hot is that, which in this case may be more appropriate… Back in the pharmacy world, lots to talk about – from CVS […]

Read More

ICER Weekly View 08-10-18

From the desk of Mitchell Stein   Good morning. I talk about randomized controlled trials a lot. Given the subject of this newsletter, that makes sense. This week, two items give us the opportunity for a great primer on the topic – see the first entry in Industry News below for more. Of course, we’ll […]

Read More

ICER Weekly View 08-03-18

From the desk of Mitchell Stein   Good morning. On Twitter – what do you mean you’re not following me (@mhstein) on Twitter – there is a construct that goes something like “two things can be true at the same time” or “these two things are both true” or “it can be hard to focus, […]

Read More

ICER Weekly View 07-27-18

From the desk of Mitchell Stein   Good morning. I’m always fascinated by the early stages of a story when the narrative hasn’t quite jelled. That’s the case this week with Biogen/Eisai release of data on the study showing a benefit from their Alzheimer’s drug. Some publications were popping the champagne while some were focusing on […]

Read More

ICER Weekly View 07-20-18

From the desk of Mitchell Stein   Good morning. I’m old enough to remember when policy proposals in DC slowed down during the summer. It was way back, like two or three years ago… Whenever it was, it’s certainly not the case now with today’s 24/7 news cycle. The point was driven home this week […]

Read More

ICER Weekly View 07-13-18

From the desk of Mitchell Stein   Good morning. I’m trying to make this newsletter more streamlined – but, between taking a week off and so much drug pricing news, I fear I may have backslid a bit this week. I hope you can find it in your heart to forgive me. With so much […]

Read More

ICER Weekly View 06-29-18

From the desk of Mitchell Stein   Good morning. An editorial note. I won’t be publishing next week due to the July 4 holiday. Weekly View will return on Friday, July 13. Thank you Amazon – like many, I was a bit distracted this week by the flurry of news. However, Amazon pulled my wonkish […]

Read More

Sign-up to have the Weekly View delivered to your inbox every Friday morning.

SIGN UP